Mobile Health in Urology: The Good, the Bad and the Ugly.
applications
apps
eHealth
mHealth
urology
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
03 Apr 2020
03 Apr 2020
Historique:
received:
22
02
2020
revised:
27
03
2020
accepted:
30
03
2020
entrez:
9
4
2020
pubmed:
9
4
2020
medline:
9
4
2020
Statut:
epublish
Résumé
Our aim is to present the current position of mobile health (mHealth) and the delivery of healthcare services via mobile communication devices in urology. We conducted a literature review of urology mHealth papers on PubMed. Results indicate that mHealth is becoming ubiquitous in contemporary healthcare systems. Although its potential has been shown, urology lags behind other areas, representing just 0.1% of the 300,000 available medical apps in the Apple App Store and Google Play Store. Furthermore, there is a lack of expert healthcare professional involvement in app development. To avoid harm, it is critical that the scientific accuracy, patient privacy, and user safety of urology mHealth applications are assured. This is because there is no globally enforced medical app regulation, compulsory scientific guidelines, nor mandatory industry standards. Urologists, either individually or via scientific organizations, should have a pivotal position in the design, development, review, certification, and recommendation of apps. mHealth holds great potential in urology, as it can aid multiple stakeholders: citizens, patients, healthcare professionals, health organizations, and public authorities (e.g., Ministry of Health). Even though it is mostly used to improve existing medical activities at present, the future will include revolutionary and ground-breaking technology solutions. This innovative field should be seen by urologists as an opportunity to provide greater care to our patients and better tools and knowledge to our peers.
Identifiants
pubmed: 32260206
pii: jcm9041016
doi: 10.3390/jcm9041016
pmc: PMC7231179
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Syst Rev. 2015 Jan 26;4:11
pubmed: 25623074
JMIR Hum Factors. 2014 Oct 13;1(1):e2
pubmed: 27025254
Eur Urol. 2014 Oct;66(4):628-32
pubmed: 25043941
PLoS One. 2015 May 18;10(5):e0125547
pubmed: 25984916
JMIR Mhealth Uhealth. 2014 May 22;2(2):e25
pubmed: 25099928
J Med Internet Res. 2018 May 01;20(5):e10235
pubmed: 29716883
Lancet Diabetes Endocrinol. 2016 Jan;4(1):52-63
pubmed: 26653067
BMJ. 2012 Jan 27;344:e256
pubmed: 22286508
CA Cancer J Clin. 2014 Nov-Dec;64(6):377-88
pubmed: 25200391
Transl Androl Urol. 2018 Feb;7(1):170-181
pubmed: 29594031
Health Informatics J. 2015 Dec;21(4):253-66
pubmed: 24621929
Cochrane Database Syst Rev. 2017 Apr 12;4:CD001431
pubmed: 28402085
Transl Behav Med. 2014 Dec;4(4):363-71
pubmed: 25584085
Can J Diabetes. 2014 Feb;38(1):17-21
pubmed: 24485208
Behav Med. 2001 Fall;27(3):111-20
pubmed: 11985184
JMIR Mhealth Uhealth. 2016 May 20;4(2):e49
pubmed: 27207211
BMC Med. 2012 May 08;10:46
pubmed: 22569114
Breast. 2014 Oct;23(5):683-9
pubmed: 25153432